Advancing first-in-class IKKalpha inhibitors to commercialisation and clinical application.

Project: Internally funded project

Project Details

Description

Impact Acceleration Account EPSRC- Internally Awarded
StatusFinished
Effective start/end date1/07/1731/10/17

Keywords

  • IAA